5-Chloro-3-(2-trimethylsilylethynyl)pyrazin-2-amine, 97%, 250mg

1,4-DIMETHYLPYRROLID-2-ONE, 95%, 250mg

N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide, 10mg

6-CHLORO-3-HYDRAZINYL-4-PYRIDAZINECARBOXYLIC ACID, 95.0%, 250mg

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 0.35 µm, 1 Piece(s)

4-tert-Octylresorcinol>99.0%(GC)25g

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(1H-imidazol-5-yl)propanoate, 95.0%, 25g

1-(tert-Butoxycarbonyl)-4-methylpiperidine-4-carboxylic Acid>98.0%(GC)1g

Ethyl 3-(4-(benzyloxy)-3,5-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate, 98%, 1g

(2-Bromoethyl)phosphonic acid, 95.0%, 1g

2-(2-Fluoro-4-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 100mg

N,N'-1,3-Phenylenedimaleimide>97.0%(GC)500g

Pyrazine-2,6-diamine hydrochloride, 95.0%, 1g